...
首页> 外文期刊>American Journal of Physiology >Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching
【24h】

Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching

机译:肌肉特定的Pikfyve基因破坏会导致葡萄糖耐受不良,胰岛素抵抗,肥胖和高胰岛素血症,但不会引起肌肉纤维类型转换

获取原文
获取原文并翻译 | 示例

摘要

The evolutionarily conserved kinase PIKfyve that synthesizes PtdIns5P and PtdInsBeta,5)P2 has been implicated in insulin-regulated GLUT4 translocation/ glucose entry in 3T3-L1 adipocytes. To decipher PIKfyve's role in muscle and systemic glucose metabolism, here we have developed a novel mouse model with Pikfyve gene disruption in striated muscle (MPIfKO). These mice exhibited systemic glucose intolerance and insulin resistance at an early age but had unaltered muscle mass or proportion of slow/fast-twitch muscle fibers. Insulin stimulation of in vivo or ex vivo glucose uptake and GLUT4 surface translocation was severely blunted in skeletal muscle. These changes were associated with premature attenuation of Akt phosphorylation in response to in vivo insulin, as tested in young mice. Starting at 10-11 wk of age, MPIfKO mice progressively accumulated greater body weight and fat mass. Despite increased adiposity, serum free fatty acid and triglyc-eride levels were normal until adulthood. Together with the undetect-able lipid accumulation in liver, these data suggest that lipotoxicity and muscle fiber switching do not contribute to muscle insulin resistance in MPIfKO mice. Furthermore, the 80% increase in total fat mass resulted from increased fat cell size rather than altered fat cell number. The observed profound hyperinsulinemia combined with the documented increases in constitutive Akt activation, in vivo glucose uptake, and gene expression of key enzymes for fatty acid biosynthesis in MPIfKO fat tissue suggest that the latter is being sensitized for de novo lipid anabolism. Our data provide the first in vivo evidence that PIKfyve is essential for systemic glucose homeostasis and insulin-regulated glucose uptake/GLUT4 translocation in skeletal muscle.
机译:合成PtdIns5P和PtdInsBeta,5)P2的进化保守激酶PIKfyve与3T3-L1脂肪细胞中胰岛素调节的GLUT4易位/葡萄糖进入有关。为了解释PIKfyve在肌肉和全身葡萄糖代谢中的作用,在这里我们开发了一种新型小鼠模型,其横纹肌中有Pikfyve基因破坏(MPIfKO)。这些小鼠在早期就表现出全身性的葡萄糖耐量和胰岛素抵抗,但肌肉质量没有改变,慢/快肌纤维比例也没有改变。体内或体外葡萄糖摄取和GLUT4表面易位的胰岛素刺激在骨骼肌中严重减弱。如在年轻小鼠中测试的,这些变化与响应体内胰岛素的Akt磷酸化的过早减弱有关。从10-11周龄开始,MPIfKO小鼠逐渐积累了更大的体重和脂肪量。尽管肥胖增加,但是直到成年之前血清游离脂肪酸和甘油三酸酯水平仍是正常的。这些数据与肝脏中无法检测到的脂质蓄积一起,表明脂毒性和肌肉纤维转换对MPIfKO小鼠的肌肉胰岛素抵抗没有贡献。此外,总脂肪量增加80%是由于增加了脂肪细胞的大小,而不是改变了脂肪细胞的数量。观察到的严重的高胰岛素血症与MPIFKO脂肪组织中脂肪酸生物合成中脂肪酸生物合成关键酶的组成型Akt激活,体内葡萄糖摄取和关键酶基因表达的增加相结合,表明后者正在对从头脂质合成代谢敏感。我们的数据提供了第一个体内证据,证明PIKfyve对于全身性葡萄糖稳态和骨骼肌中胰岛素调节的葡萄糖摄取/ GLUT4易位至关重要。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号